J9382 Zenocutuzumab-zbco - CanMED: HCPCS

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Zenocutuzumab-zbco

Brand Name:

Bizengri

Strength:

1mg

HCPCS:

J9382

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

HER2, HER3

Oral (Y/N):

No

FDA Approval Year:

2024

FDA Discontinuation Year:

CMS Effective Date:

July 9, 2025

CMS Discontinuation Date:

Status:

In Use